Is It Still Worth Buying GSK After a 46% Rally in Shares This Year
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Stock picking may pay off in certain market conditions and for investors with time and expertise. Learn factors to consider before deviating from index funds.
26,454 articlesGSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Regulators revived a stalled pipeline, prompting questions for investors in Sable Offshore. This guide breaks down wh...
Geopolitics just accelerated volatility in energy markets. The rejection of a ceasefire proposal by iran has traders ...
A billionaire investor backed D-Wave Quantum in late 2024, and the stock has surged and slumped in a choppy 2026 trad...
Nvidia and Broadcom lead the AI chip market, but which one deserves a place in a modern portfolio? This guide breaks ...
Salesforce CRM faces a sharp sell-off even as its AI strategy shows real monetization. Here’s why traders are watchin...
Apple extends Broadcom’s supply agreement through 2031, anchoring cash flow and accelerating AI chip growth. Here’s w...
IonQ is set to report Q4 2025 earnings tonight, confronting a valuation that many analysts say risks outpacing the co...
Three consumer-facing stocks — Planet Fitness, Brown-Forman, and Campbell’s — moved on earnings, tariffs, and margin ...
ClearPoint Neuro's earnings are under the microscope for investors watching the medical-device niche. This analysis b...
Amazon stock fell about 3% on Friday as macro uncertainty and doubts about a $200B AI capital plan for 2026 weigh on ...
Major banks reduced their Figma price targets even as the company posted rapid revenue growth, signaling that AI comp...